Stepan Reports Strong Q3 2026 Results Driven by Volume Growth and Cost Savings
Stepan (SCL) reported robust third-quarter 2026 financial results, highlighted by an 18% increase in adjusted EBITDA to $66 million. Despite flat demand in the broader chemical market, the company achieved a 7% growth in organic sales volume across all operating segments, driven largely by significant customer acquisitions in mid-sized tier-two and tier-three accounts. The company successfully protected its margins against rising feedstock costs through contractual pass-through mechanisms and targeted price increases. Additionally, Stepan's 'Project Catalyst' efficiency program exceeded expectations, reaching a $23 million run-rate savings. With net debt leverage decreasing to 2.4 times earnings and positive free cash flow, management remains optimistic about full-year growth and continued deleveraging.
Topics: EBITDA increase market share expansion organic sales growth specialty chemicals